3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol and oxidopamine

3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol has been researched along with oxidopamine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chancellor, MB; De Groat, WC; Kuno, S; Seki, S; Yoshimura, N	1

Other Studies

1 other study(ies) available for 3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol and oxidopamine

Article	Year
Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal pathway. British journal of pharmacology, 2003, Volume: 139, Issue:8 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzopyrans; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Injections, Intravenous; Injections, Intraventricular; Male; Microinjections; Oxazines; Oxidopamine; Parkinson Disease; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Substantia Nigra; Urinary Bladder; Urination	2003

Article

Year

Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal pathway.

British journal of pharmacology, 2003, Volume: 139, Issue:8

Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzopyrans; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Injections, Intravenous; Injections, Intraventricular; Male; Microinjections; Oxazines; Oxidopamine; Parkinson Disease; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Substantia Nigra; Urinary Bladder; Urination

2003